Article PDF
Avoid common mistakes on your manuscript.
Références
Bone RC, Balk RA, Cerra FB, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–55
Bone RC, Fischer CJ, Clemmer TP, et al (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–8
Ziegler EJ, Fischer CJ, Sprung CL, et al (1991) Treatment of gram-negative bacteremia and septic shock with HA-JA human monoclonal anti-body against endotoxin; N Engl J Med 324:429–36
Fisher CJ, Slotman GJ, Opal SM, et al (1994) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized open-label, placebo controlled multicenter trial. Crit Care Med 22:12–21
Bone RC, Grodzin CJ Balk RA (1997) Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235–43
Levy MM Fink MP, Marshall JC, et al (2003) 2001 SCCM/ ESICM/ACCP/ATS/SIS International sepsis definition conference. Crit Care Med 31:1250–6
Kaukonen KM, Bailey M, Pilcher D (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372:1629–38
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beloncle, F., Asfar, P. Quelle évolution conceptuelle pour le SIRS ?. Réanimation 25, 261–262 (2016). https://doi.org/10.1007/s13546-015-1151-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13546-015-1151-6